195 related articles for article (PubMed ID: 25715974)
1. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
[TBL] [Abstract][Full Text] [Related]
2. Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.
Markar SR; Schmidt H; Kunz S; Bodnar A; Hubka M; Low DE
J Gastrointest Surg; 2014 Jul; 18(7):1238-46. PubMed ID: 24777435
[TBL] [Abstract][Full Text] [Related]
3. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).
Chiu PW; Chan AC; Leung SF; Leong HT; Kwong KH; Li MK; Au-Yeung AC; Chung SC; Ng EK
J Gastrointest Surg; 2005; 9(6):794-802. PubMed ID: 16187480
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer.
Takeuchi M; Kawakubo H; Mayanagi S; Yoshida K; Fukuda K; Nakamura R; Suda K; Wada N; Takeuchi H; Kitagawa Y
J Gastrointest Surg; 2018 Nov; 22(11):1881-1889. PubMed ID: 29980971
[TBL] [Abstract][Full Text] [Related]
5. Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.
Ising MS; Marino K; Trivedi JR; Rojan AA; Dunlap NE; van Berkel V; Fox MP
J Gastrointest Surg; 2019 Apr; 23(4):670-678. PubMed ID: 30788714
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.
Nobel TB; Dave N; Eljalby M; Xing X; Barbetta A; Hsu M; Tan KS; Janjigian Y; Bains MS; Sihag S; Jones DR; Molena D
Ann Thorac Surg; 2020 Feb; 109(2):329-336. PubMed ID: 31614136
[TBL] [Abstract][Full Text] [Related]
7. Salvage Esophagectomy After Definitive Chemoradiotherapy for Squamous Cell Esophageal Cancer: A Propensity Score Matching Study in a High-Volume Center.
Pan J; Liu Z; Yang Y; Li B; Hua R; Guo X; Sun Y; Li C; Li Z
World J Surg; 2023 Aug; 47(8):2003-2012. PubMed ID: 37097320
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Chang X; Deng L; Ni W; Li C; Han W; Gao LR; Wang S; Zhou Z; Chen D; Feng Q; Liang J; Bi N; Lv J; Gao S; Mao Y; Xue Q; Xiao Z
BMC Cancer; 2020 Sep; 20(1):877. PubMed ID: 32928136
[TBL] [Abstract][Full Text] [Related]
9. Treatment of local recurrence of esophageal cancer following Ivor-Lewis esophagectomy-Experiences of a high-volume center.
Knipper K; Krey T; Lyu SI; Jung JO; Wirsik NM; Fuchs HF; Schröder W; Schlößer HA; Popp FC; Quaas A; Bruns CJ; Schmidt T
World J Surg; 2024 Jun; 48(6):1414-1423. PubMed ID: 38554145
[TBL] [Abstract][Full Text] [Related]
10. Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.
Low DE; Kunz S; Schembre D; Otero H; Malpass T; Hsi A; Song G; Hinke R; Kozarek RA
J Gastrointest Surg; 2007 Nov; 11(11):1395-402; discussion 1402. PubMed ID: 17763917
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.
Kunisaki C; Makino H; Takagawa R; Yamamoto N; Nagano Y; Fujii S; Kosaka T; Ono HA; Otsuka Y; Akiyama H; Ichikawa Y; Shimada H
J Gastrointest Surg; 2008 May; 12(5):802-10. PubMed ID: 17952515
[TBL] [Abstract][Full Text] [Related]
12. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan.
Okumura H; Mori N; Tanaka T; Morita M; Toh Y; Saeki H; Maehara Y; Nakamura K; Honda H; Yoshida N; Baba H; Natsugoe S
Dis Esophagus; 2016 Nov; 29(8):1135-1143. PubMed ID: 26542524
[TBL] [Abstract][Full Text] [Related]
14. Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy.
Nakajima M; Domeki Y; Satomura H; Takahashi M; Sugawara A; Muroi H; Sasaki K; Yamaguchi S; Miyazaki T; Kuwano H; Kato H
Int Surg; 2014; 99(4):452-7. PubMed ID: 25058783
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopically assisted versus open oesophagectomy for patients with oesophageal cancer-the Randomised Oesophagectomy: Minimally Invasive or Open (ROMIO) study: protocol for a randomised controlled trial (RCT).
Brierley RC; Gaunt D; Metcalfe C; Blazeby JM; Blencowe NS; Jepson M; Berrisford RG; Avery KNL; Hollingworth W; Rice CT; Moure-Fernandez A; Wong N; Nicklin J; Skilton A; Boddy A; Byrne JP; Underwood T; Vohra R; Catton JA; Pursnani K; Melhado R; Alkhaffaf B; Krysztopik R; Lamb P; Culliford L; Rogers C; Howes B; Chalmers K; Cousins S; Elliott J; Donovan J; Heys R; Wickens RA; Wilkerson P; Hollowood A; Streets C; Titcomb D; Humphreys ML; Wheatley T; Sanders G; Ariyarathenam A; Kelly J; Noble F; Couper G; Skipworth RJE; Deans C; Ubhi S; Williams R; Bowrey D; Exon D; Turner P; Daya Shetty V; Chaparala R; Akhtar K; Farooq N; Parsons SL; Welch NT; Houlihan RJ; Smith J; Schranz R; Rea N; Cooke J; Williams A; Hindmarsh C; Maitland S; Howie L; Barham CP
BMJ Open; 2019 Nov; 9(11):e030907. PubMed ID: 31748296
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in multidisciplinary treatment for patients with esophageal cancer.
Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y
Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer.
Ling FC; Hoelscher AH; Vallböhmer D; Schmidt D; Picker S; Gathof BS; Bollschweiler E; Schneider PM
J Gastrointest Surg; 2009 Apr; 13(4):581-6. PubMed ID: 19152023
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.
Schuring N; Stam WT; Plat VD; Kalff MC; Hulshof MCCM; van Laarhoven HWM; Derks S; van der Peet DL; van Berge Henegouwen MI; Daams F; Gisbertz SS
Eur J Surg Oncol; 2023 Oct; 49(10):106947. PubMed ID: 37355392
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy.
Honing J; Koch AD; Siersema PD; Spaander M
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883
[TBL] [Abstract][Full Text] [Related]
20. Applicability and feasibility of incorporating minimally invasive esophagectomy at a high volume center.
Willer BL; Mittal SK; Worrell SG; Mumtaz S; Lee TH
J Gastrointest Surg; 2010 Aug; 14(8):1201-6. PubMed ID: 20532664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
